Published in Blood Weekly, February 14th, 2008
"The effects on lipids of pioglitazone are more favourable than those of rosiglitazone. Indeed, pioglitazone appears...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2008-02-14)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.